ChronoScale Holdings Corp
Close on Oct 19, 2026
- Market cap
- $2.18B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2027 Ended Aug 31, 2026 | Oct 15, 2026 | After market close | $41.50M | $-0.18 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Jan 13, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 28, 2024 | After market close | $4.10M | $-0.10 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 29, 2024 | After market close | $5.00M | $-0.13 | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 29, 2024 | After market close | $3.80M | $-0.20 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 5, 2024 | After market close | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Oct 26, 2023 | After market close | $4.60M | $-0.24 | – |
| Q2 FY2023 Ended Jun 30, 2023 | Jul 27, 2023 | After market close | $4.70M | $-0.31 | – |
| Q1 FY2023 Ended Mar 31, 2023 | Apr 27, 2023 | After market close | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 28, 2023 | After market close | – | – | – |
| Q3 FY2022 Ended Sep 30, 2022 | Nov 3, 2022 | After market close | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Jul 28, 2022 | After market close | – | – | – |
Press releases
Announcements ChronoScale filed with the SEC
Reports Fiscal First Quarter 2027 Results
Results of operations · EX-99.1 to Form 8-K
Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Announces AI Infrastructure Partnership with Microsoft
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Discussion and Analysis of Financial Condition and Results of Operations of Cloud
Other events · EX-99.1 to Form 8-K/A
EX-99.2 to Form 8-K/A
Other events · EX-99.2 to Form 8-K/A
PRO FORMA COMBINED FINANCIAL INFORMATION
Other events · EX-99.3 to Form 8-K/A
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:
Unregistered share sale · Other events · EX-99.1 to Form 8-K
101 Glacier Point, Suite A
Unregistered share sale · Other events · EX-99.2 to Form 8-K
Ekso Bionics Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Announces Reverse Stock Split
Other events · EX-99.1 to Form 8-K
Ekso Bionics Announces Reverse Stock Split
Shareholder vote results · Other events · EX-99.1 to Form 8-K
Ekso Bionics Announces First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Ekso Bionics Announces Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Announces First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Annual Revenue of $18.3 Million
Results of operations · EX-99.1 to Form 8-K
FORM OF SECURITIES PURCHASE AGREEMENT
Other events · EX-99.1 to Form 8-K
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Report Record Revenues of $4.7 Million in Second Quarter 2023
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Fourth Quarter and Year End 2022 Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego ® Product Line From Parker Hannifin Corporation
Acquisition or disposition completed · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Ekso Bionics Reports Third Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Second Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports First Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Fourth Quarter and Year End 2021 Results
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Announces Leadership Transition
Executive or director change · Other events · EX-99.1 to Form 8-K
Ekso Bionics Reports Preliminary Fourth Quarter
Results of operations · EX-99.1 to Form 8-K
Ekso Bionics Reports Third Quarter 2021 Results
Results of operations · EX-99.1 to Form 8-K